JPMORGAN CHASE & CO - FLEXION THERAPEUTICS INC ownership

FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 133 filers reported holding FLEXION THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$5,067,000
-16.1%
830,546
+13.1%
0.00%0.0%
Q2 2021$6,041,000
-7.0%
734,166
+1.1%
0.00%0.0%
Q1 2021$6,499,000
+5.0%
726,154
+35.3%
0.00%0.0%
Q4 2020$6,192,000
+43.9%
536,601
+29.7%
0.00%0.0%
Q3 2020$4,304,000
-17.9%
413,787
+3.8%
0.00%0.0%
Q2 2020$5,242,000
+281.0%
398,666
+127.9%
0.00%
Q1 2020$1,376,000
-55.1%
174,912
+18.1%
0.00%
-100.0%
Q4 2019$3,067,000
+66.8%
148,149
+10.4%
0.00%
Q3 2019$1,839,000
+22.7%
134,173
+5.2%
0.00%
Q2 2019$1,499,000
-11.4%
127,578
-5.8%
0.00%
Q1 2019$1,691,000
+3.6%
135,494
-6.1%
0.00%
Q4 2018$1,633,000
-42.7%
144,279
-5.3%
0.00%
-100.0%
Q3 2018$2,851,000
-22.8%
152,355
+6.6%
0.00%0.0%
Q2 2018$3,694,000
+8.9%
142,895
-5.6%
0.00%0.0%
Q1 2018$3,393,000
-18.5%
151,397
-8.9%
0.00%0.0%
Q4 2017$4,161,000
+6.0%
166,171
+1.1%
0.00%0.0%
Q3 2017$3,927,000
+16.0%
164,400
-1.8%
0.00%0.0%
Q2 2017$3,384,000
+9.7%
167,350
+46.0%
0.00%0.0%
Q1 2017$3,084,000
+28.9%
114,587
-8.9%
0.00%0.0%
Q4 2016$2,393,000
+2.9%
125,822
+5.7%
0.00%0.0%
Q3 2016$2,326,000
+38.8%
119,050
+6.3%
0.00%
Q2 2016$1,676,000
+54.3%
111,975
-5.1%
0.00%
Q1 2016$1,086,000
-50.3%
118,000
+4.1%
0.00%
-100.0%
Q4 2015$2,184,000
-40.4%
113,355
-58.3%
0.00%0.0%
Q2 2014$3,662,000
-32.1%
271,676
-17.2%
0.00%0.0%
Q1 2014$5,397,000328,0750.00%
Other shareholders
FLEXION THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Novo Holdings A/S 1,500,000$36,270,0004.72%
Gagnon Advisors, LLC 108,498$2,623,0001.99%
NEXTHERA CAPITAL LP 271,136$6,556,0001.69%
KINGDON CAPITAL MANAGEMENT, L.L.C. 883,321$21,359,0001.39%
GILDER GAGNON HOWE & CO LLC 3,961,647$95,793,0001.35%
GAGNON SECURITIES LLC 144,331$3,490,0001.30%
MILLER VALUE PARTNERS, LLC 1,181,325$28,564,0001.23%
SCHOLTZ & COMPANY, LLC 55,250$1,336,0001.05%
ARDSLEY ADVISORY PARTNERS LP 175,000$4,232,0000.56%
Ratan Capital Management LP 32,077$776,0000.47%
View complete list of FLEXION THERAPEUTICS INC shareholders